Use of methotrexate delivered in nanoparticles that bind to low-density lipoprotein (LDL) receptors for the treatment of patients with COVID-19 infection and respiratory distress syndrome.

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    N/A
  • Funder

    University of São Paulo
  • Research Location

    Brazil
  • Lead Research Institution

    N/A
  • Research Priority Alignment

    N/A
  • Research Category

    Clinical characterisation and management
  • Research Subcategory

    Supportive care, processes of care and management
  • Special Interest Tags

    N/A
  • Study Type

    Unspecified
  • Clinical Trial Details

    N/A
  • Broad Policy Alignment

    Pending
  • Age Group

    Unspecified
  • Vulnerable Population

    Unspecified
  • Occupations of Interest

    Unspecified

Abstract